Antiphospholipid Syndrome and Pregnancy

Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.

Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.

Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.

Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.

Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.

On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.

SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.

Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.